Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wenlin Chen

Showing results (151-160 of 156) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 156 results.
Discover Oncology|March 22, 2024
A prognostic model for overall survival in recurrent glioma patients treated with bevacizumab-containing therapyShanmu Jin, Wenlin Chen, Xiaopeng Guo, et al.
Cancer Medicine|January 13, 2025
TERTp Mutation and its Prognostic Value in Glioma Patients Under the 2021 WHO Classification: A Real-World StudyHao Xing, Delin Liu, Junlin Li, et al.
Frontiers in Oncology|July 24, 2023
Histological and molecular glioblastoma, IDH-wildtype: a real-world landscape using the 2021 WHO classification of central nervous system tumorsXiaopeng Guo, Lingui Gu, Yilin Li, et al.
Frontiers in Neuroscience|April 10, 2024
Clinical roles of <i>EGFR</i> amplification in diffuse gliomas: a real-world study using the 2021 WHO classification of CNS tumorsHai Wang, Xin Zhang, Jiahui Liu, et al.
BMC Neurology|June 14, 2024
The molecular signature and prognosis of glioma with preoperative intratumoral hemorrhage: a retrospective cohort analysisYixin Shi, Xiaoman Kang, Yulu Ge, et al.
Journal of Molecular Neuroscience : MN|February 5, 2024
Molecular Determinants of Neurocognitive Deficits in Glioma: Based on 2021 WHO ClassificationKun Zhang, Tianrui Yang, Yu Xia, et al.
Pageof 16

Showing results (151-160 of 156) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 156 results.
Discover Oncology|March 22, 2024
A prognostic model for overall survival in recurrent glioma patients treated with bevacizumab-containing therapyShanmu Jin, Wenlin Chen, Xiaopeng Guo, et al.
Cancer Medicine|January 13, 2025
TERTp Mutation and its Prognostic Value in Glioma Patients Under the 2021 WHO Classification: A Real-World StudyHao Xing, Delin Liu, Junlin Li, et al.
Frontiers in Oncology|July 24, 2023
Histological and molecular glioblastoma, IDH-wildtype: a real-world landscape using the 2021 WHO classification of central nervous system tumorsXiaopeng Guo, Lingui Gu, Yilin Li, et al.
Frontiers in Neuroscience|April 10, 2024
Clinical roles of <i>EGFR</i> amplification in diffuse gliomas: a real-world study using the 2021 WHO classification of CNS tumorsHai Wang, Xin Zhang, Jiahui Liu, et al.
BMC Neurology|June 14, 2024
The molecular signature and prognosis of glioma with preoperative intratumoral hemorrhage: a retrospective cohort analysisYixin Shi, Xiaoman Kang, Yulu Ge, et al.
Journal of Molecular Neuroscience : MN|February 5, 2024
Molecular Determinants of Neurocognitive Deficits in Glioma: Based on 2021 WHO ClassificationKun Zhang, Tianrui Yang, Yu Xia, et al.
Pageof 16